CICULATORY LEVELS OF RETINOL-BINDING PROTEIN 4 IN PATIENTS WITH TYPE 2 DIABETES, COMPLICATED BY NON-ALCOHOLIC FATTY LIVER DISEASE

It was determined levels of retinol-binding protein 4 (RBP4) in the blood of patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease or its absence. In patients with type 2 diabetes was verified a significant increase of circulating levels of RBP4, the severity of which was sig...

Full description

Saved in:
Bibliographic Details
Published inProblems of Endocrine Pathology Vol. 48; no. 2; pp. 7 - 14
Main Authors Tyzhnenko, T. V., Karachentsev, Y. I., Kravchun, N. A., Poltorak, V. V., Gorshunska, M. Y., Jаnsen, E., Krasova, N. S., Leshchenko, Zh. A., Gladkih, A. I., Chernyavskaya, I. V., Cherniaieva, A. A., Opaleiko, Y. A., Pochernyayev, A. K., Zavadska, N. V.
Format Journal Article
LanguageEnglish
Published 22.05.2014
Online AccessGet full text

Cover

More Information
Summary:It was determined levels of retinol-binding protein 4 (RBP4) in the blood of patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease or its absence. In patients with type 2 diabetes was verified a significant increase of circulating levels of RBP4, the severity of which was significantly higher in non-alcoholic fatty liver disease, as well as their direct correlation with the presence of complications. The data obtained justify the use of indicators of circulatory levels of RBP4 as a new marker of the risk of non-alcoholic fatty liver disease in patients with type 2 diabetes and the selection of anti-diabetic therapy.
ISSN:2227-4782
2518-1432
DOI:10.21856/j-PEP.2014.2.01